Legacy App users can now access the Health Portal – just reset your password using email as username.

Risks of Excessive Phlebotomy on Testosterone & Steroids – Case Study

Risks of Excessive Phlebotomy on Testosterone & Steroids – Case Study

Member Access Required

Sign in or join the Health Portal to watch this video.

Join Now

Timeline

Timestamp
Topic
00:00
Phlebotomy is introduced as a common response to elevated hematocrit on testosterone use. The warning is that treating a number alone can create avoidable downstream harms.
01:24
A case study begins with a man on stable testosterone who feels generally well. Mildly high hematocrit is noted, and infrequent donation is discussed as an option.
03:59
Anxiety and awareness of heartbeat appear, and the man assumes blood thickness is responsible. Instead of seeking medical guidance, he purchases home kits and starts bleeding himself.
05:20
Follow-up labs show lower hemoglobin and hematocrit, yet deeper iron studies reveal depletion. Low ferritin and low saturation demonstrate that excessive blood removal can drain reserves.
07:52
Androgen induced erythrocytosis is defined, and polycythemia is discussed as a related endpoint. Symptoms are emphasized because reference ranges differ and do not prove danger alone.
09:36
Risk factors are reviewed, including genetic susceptibility and obstructive sleep apnea effects. Low oxygen during sleep is described as a strong signal for higher red cell production.
13:46
Venous clot risks are described, including DVT and pulmonary embolism scenarios. The transcript also mentions arterial outcomes like heart attacks and strokes in high-risk men.
15:14
Management focuses on lowering testosterone dose and stopping additional steroids when possible. Addressing sleep apnea and other contributors is framed as more effective than endless bleeding.
17:13
Careful phlebotomy is reserved for persistent high hematocrit after risks are addressed. Team-based care with primary doctors, cardiology, and hematology is strongly encouraged.

Video Summary

Excessive phlebotomy is presented as a growing problem among men using testosterone or anabolic steroids. Different men respond differently to androgens, so red blood cell changes are never identical across users. Some men truly need cautious blood removal, yet many others do not need it routinely. The case study begins with a middle aged man on stable TRT who feels well. His hematocrit is slightly above a common reference cutoff, yet he reports no clear symptoms. A voluntary blood donation every six months is described as an optional conservative approach. The warning is that chasing a lab flag without context can create new medical problems.

After leaving the clinic, the man becomes anxious about his heartbeat and assumes thick blood is the cause. Instead of calling his physician, he buys home phlebotomy kits and removes multiple units himself. Over roughly several months he removes six units, similar to repeated full blood donations. Follow-up testing shows lower hemoglobin and hematocrit, but iron studies reveal significant depletion. Percent saturation falls below the stated reference range, and ferritin drops to a very low value. The transcript emphasizes that iron storage markers matter, not only a complete blood count number. This pattern illustrates how excessive bleeding can harm physiology even when anemia is not obvious.

The discussion names this pattern androgen induced erythrocytosis, which can progress toward polycythemia in susceptible men. Symptoms and risk factors are emphasized, because reference ranges vary across laboratories and experts. Obstructive sleep apnea is highlighted as a driver, since low nighttime oxygen signals the body to raise red cells. Clot concerns are reviewed, including DVT and pulmonary embolism on the venous side of circulation. On the arterial side, heart attack and stroke are framed as possible outcomes when other risks already exist. Management centers on the lowest effective testosterone dose, stopping additional steroids, and treating sleep apnea aggressively. Only limited phlebotomy is suggested, sometimes as little as twice yearly, coordinated with a medical team.

Drug Callouts

Drug
Description
Testosterone
Testosterone is an androgen hormone medication prescribed for clinically confirmed male hypogonadism. It is discussed because TRT can raise hematocrit, prompting some men to consider phlebotomy.

Condition Callouts

Condition
Description
Androgen-induced erythrocytosis
Erythrocytosis is an abnormal increase in red blood cell mass and hemoglobin concentration. The transcript describes androgen induced erythrocytosis as a common TRT-related pattern requiring context.
Polycythemia
Polycythemia is a condition with elevated red blood cells that can thicken blood. It is discussed as a potential progression when hemoglobin and hematocrit rise substantially on androgens.
Obstructive sleep apnea
Obstructive sleep apnea is repeated upper airway obstruction during sleep that lowers oxygen levels. It is highlighted as a driver of higher red cell production, so CPAP adherence is emphasized.
Deep vein thrombosis (DVT)
Deep vein thrombosis is a blood clot forming in a deep vein, usually within the leg. It is mentioned as a venous risk when hematocrit is very high and other factors accumulate.
Pulmonary embolism
A pulmonary embolism occurs when a clot travels to the lungs and blocks blood flow. It is paired with DVT as a feared complication in discussions about thick blood and clotting.
Hypertension
Hypertension is persistently elevated blood pressure that damages vessels and organs over time. It is listed among risk factors that can combine with high hematocrit and raise event risk.
Heart attack
A heart attack is myocardial injury caused by reduced coronary blood flow and oxygen delivery. It is cited as a possible arterial event when plaque, risk factors, and thick blood overlap.
Stroke
A stroke is brain injury from interrupted blood flow, usually from clotting or bleeding. It is referenced alongside heart attack when reviewing arterial consequences of multiple stacked risks.
Iron deficiency
Iron deficiency is inadequate iron stores that can impair oxygen transport and energy. It is illustrated by very low ferritin and low saturation after repeated self-performed phlebotomy.

Key Takeaways

  • Not every man on testosterone needs phlebotomy, especially without symptoms or risks.
  • Excessive self-directed bleeding can drop ferritin and saturation, creating iron depletion problems.
  • Androgen induced erythrocytosis should be judged using symptoms, not only lab flags.
  • Sleep apnea and low nighttime oxygen can push red cell production higher on TRT.
  • Use the lowest effective testosterone dose and limited phlebotomy with a coordinated medical team.